176 related articles for article (PubMed ID: 25199534)
1. Upregulation of heat shock factor 1 transcription activity is associated with hepatocellular carcinoma progression.
Li S; Ma W; Fei T; Lou Q; Zhang Y; Cui X; Qin X; Zhang J; Liu G; Dong Z; Ma Y; Song Z; Hu Y
Mol Med Rep; 2014 Nov; 10(5):2313-21. PubMed ID: 25199534
[TBL] [Abstract][Full Text] [Related]
2. Glucose regulates heat shock factor 1 transcription activity via mTOR pathway in HCC cell lines.
Ma W; Zhang Y; Mu H; Qing X; Li S; Cui X; Lou Q; Ma Y; Pu H; Hu Y
Cell Biol Int; 2015 Nov; 39(11):1217-24. PubMed ID: 26010766
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3σ induces heat shock protein 70 expression in hepatocellular carcinoma.
Liu CC; Jan YJ; Ko BS; Wu YM; Liang SM; Chen SC; Lee YM; Liu TA; Chang TC; Wang J; Shyue SK; Sung LY; Liou JY
BMC Cancer; 2014 Jun; 14():425. PubMed ID: 24923353
[TBL] [Abstract][Full Text] [Related]
4. HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells.
Zhang N; Wu Y; Lyu X; Li B; Yan X; Xiong H; Li X; Huang G; Zeng Y; Zhang Y; Lian J; Ni Z; He F
Cancer Lett; 2017 Nov; 409():81-90. PubMed ID: 28889000
[TBL] [Abstract][Full Text] [Related]
5. Heat shock factor 1 promotes invasion and metastasis of hepatocellular carcinoma in vitro and in vivo.
Fang F; Chang R; Yang L
Cancer; 2012 Apr; 118(7):1782-94. PubMed ID: 22009757
[TBL] [Abstract][Full Text] [Related]
6. Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value.
Evert M; Frau M; Tomasi ML; Latte G; Simile MM; Seddaiu MA; Zimmermann A; Ladu S; Staniscia T; Brozzetti S; Solinas G; Dombrowski F; Feo F; Pascale RM; Calvisi DF
Br J Cancer; 2013 Nov; 109(10):2654-64. PubMed ID: 24136149
[TBL] [Abstract][Full Text] [Related]
7. Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor-κB/mitogen-activated protein kinase.
Chuma M; Sakamoto N; Nakai A; Hige S; Nakanishi M; Natsuizaka M; Suda G; Sho T; Hatanaka K; Matsuno Y; Yokoo H; Kamiyama T; Taketomi A; Fujii G; Tashiro K; Hikiba Y; Fujimoto M; Asaka M; Maeda S
Carcinogenesis; 2014 Feb; 35(2):272-81. PubMed ID: 24130164
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Respiratory Dysfunction Induces Claudin-1 Expression via Reactive Oxygen Species-mediated Heat Shock Factor 1 Activation, Leading to Hepatoma Cell Invasiveness.
Lee JH; Lee YK; Lim JJ; Byun HO; Park I; Kim GH; Xu WG; Wang HJ; Yoon G
J Biol Chem; 2015 Aug; 290(35):21421-31. PubMed ID: 26157141
[TBL] [Abstract][Full Text] [Related]
10. HSF1 promotes the inhibition of EMT-associated migration by low glucose via directly regulating Snail1 expression in HCC cells.
Liu D; Sun L; Qin X; Liu T; Zhang S; Liu Y; Li S; Guo K
Discov Med; 2016 Sep; 22(120):87-96. PubMed ID: 27755964
[TBL] [Abstract][Full Text] [Related]
11. The natural compound cantharidin induces cancer cell death through inhibition of heat shock protein 70 (HSP70) and Bcl-2-associated athanogene domain 3 (BAG3) expression by blocking heat shock factor 1 (HSF1) binding to promoters.
Kim JA; Kim Y; Kwon BM; Han DC
J Biol Chem; 2013 Oct; 288(40):28713-26. PubMed ID: 23983126
[TBL] [Abstract][Full Text] [Related]
12. Heat-Shock protein A12A is a novel PCNA-binding protein and promotes hepatocellular carcinoma growth.
Cheng H; Cao X; Min X; Zhang X; Kong Q; Mao Q; Li R; Xue B; Fang L; Liu L; Ding Z
FEBS J; 2020 Dec; 287(24):5464-5477. PubMed ID: 32128976
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-135b, a HSF1 target, promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma.
Li Y; Xu D; Bao C; Zhang Y; Chen D; Zhao F; Ding J; Liang L; Wang Q; Liu L; Li J; Yao M; Huang S; He X
Oncotarget; 2015 Feb; 6(4):2421-33. PubMed ID: 25537516
[TBL] [Abstract][Full Text] [Related]
14. Replication Protein A 3 Is Associated with Hepatocellular Carcinoma Tumorigenesis and Poor Patient Survival.
Xiao W; Zheng J; Zhou B; Pan L
Dig Dis; 2018; 36(1):26-32. PubMed ID: 28683444
[TBL] [Abstract][Full Text] [Related]
15. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus-regulated growth of liver cancer cells occurs through the microRNA-340-5p-activating transcription factor 7-heat shock protein A member 1B axis.
Song F; Wei M; Wang J; Liu Y; Guo M; Li X; Luo J; Zhou J; Wang M; Guo D; Chen L; Sun G
Cancer Sci; 2019 May; 110(5):1633-1643. PubMed ID: 30891870
[TBL] [Abstract][Full Text] [Related]
18. CISD2 associated with proliferation indicates negative prognosis in patients with hepatocellular carcinoma.
Chen B; Shen S; Wu J; Hua Y; Kuang M; Li S; Peng B
Int J Clin Exp Pathol; 2015; 8(10):13725-38. PubMed ID: 26722601
[TBL] [Abstract][Full Text] [Related]
19. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
[TBL] [Abstract][Full Text] [Related]
20. TEAD2 as a novel prognostic factor for hepatocellular carcinoma.
Joo JS; Cho SY; Rou WS; Kim JS; Kang SH; Lee ES; Moon HS; Kim SH; Sung JK; Kwon IS; Eun HS; Lee BS
Oncol Rep; 2020 Jun; 43(6):1785-1796. PubMed ID: 32323824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]